Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Day 3 at ACC.22 | How vaccines impacted outcomes among STEMI patients with COVID-19
Tuesday, April 5, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

TAVR vs. surgery, FFR-guided PCI and DCB safety: Day 3 at ACC.22

Read our in-person coverage of the final day of ACC.22.

READ MORE >
ACC.22.jpg
Share on Twitter Share on Facebook Share on Linkedin

TAVR vs. surgery, FFR-guided PCI and DCB safety: Day 3 at ACC.22

Share on Twitter Share on Facebook Share on Linkedin
ACC.22.jpg
Read our in-person coverage of the final day of ACC.22.
READ MORE >

How the availability of vaccines impacted outcomes among STEMI patients with COVID-19

New results from the North American COVID-19 STEMI (NACMI) registry showed a 25% reduction in early mortality in 2021 compared to 2020 among STEMI patients with a confirmed COVID-19 infection. 

READ MORE >
A late-breaking study at ACC.22 showed differences in COVID-positive heart attack patients between 2020 and 2021. #ACC22 #ACC2022
Share on Twitter Share on Facebook Share on Linkedin

How the availability of vaccines impacted outcomes among STEMI patients with COVID-19

Share on Twitter Share on Facebook Share on Linkedin
A late-breaking study at ACC.22 showed differences in COVID-positive heart attack patients between 2020 and 2021. #ACC22 #ACC2022
New results from the North American COVID-19 STEMI (NACMI) registry showed a 25% reduction in early mortality in 2021 compared to 2020 among STEMI patients with a confirmed COVID-19 infection. 
READ MORE >

Featured Articles

Cholesterol medications, flu shots and heart failure: Day 2 at ACC.22

Day 2 of ACC.22 was jam-packed with late-breaking clinical trials. Read our quick rundown of what researchers shared with the public for the very first time. 

READ MORE >
Steven E. Nissen, MD, discusses his late-breaking clinical trial with panelist Vera Bittner, MD.
Share on Twitter Share on Facebook Share on Linkedin

Cholesterol medications, flu shots and heart failure: Day 2 at ACC.22

Share on Twitter Share on Facebook Share on Linkedin
Steven E. Nissen, MD, discusses his late-breaking clinical trial with panelist Vera Bittner, MD.
Day 2 of ACC.22 was jam-packed with late-breaking clinical trials. Read our quick rundown of what researchers shared with the public for the very first time. 
READ MORE >

Salt restrictions, PCI breakthroughs and a social media primer for cardiologists: Day 1 at ACC.22

Explore our on-the-ground coverage of the first day of ACC.22.

READ MORE >
ACC.22 kicked off on Saturday, April 2, in Washington, D.C.
Share on Twitter Share on Facebook Share on Linkedin

Salt restrictions, PCI breakthroughs and a social media primer for cardiologists: Day 1 at ACC.22

Share on Twitter Share on Facebook Share on Linkedin
ACC.22 kicked off on Saturday, April 2, in Washington, D.C.
Explore our on-the-ground coverage of the first day of ACC.22.
READ MORE >

Cardiology groups debut new heart failure guidelines ahead of ACC.22

The new recommendations went live just ahead of ACC.22. They can be read in full in the Journal of the American College of Cardiology, Circulation or Journal of Cardiac Failure.

READ MORE >
Cardiologist heart
Share on Twitter Share on Facebook Share on Linkedin

Cardiology groups debut new heart failure guidelines ahead of ACC.22

Share on Twitter Share on Facebook Share on Linkedin
Cardiologist heart
The new recommendations went live just ahead of ACC.22. They can be read in full in the Journal of the American College of Cardiology, Circulation or Journal of Cardiac Failure.
READ MORE >

Medtronic recalls more than 6,000 catheters due to potential damage, loss of sterility

The issue, identified during a routine inspection, appears to be related to a change in the manufacturing process. It has now been corrected, Medtronic said in a statement. 

READ MORE >
More than 6,000 IN.PACT Admiral Drug-Coated Balloons have been recalled, Medtronic announced Thursday.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic recalls more than 6,000 catheters due to potential damage, loss of sterility

Share on Twitter Share on Facebook Share on Linkedin
More than 6,000 IN.PACT Admiral Drug-Coated Balloons have been recalled, Medtronic announced Thursday.
The issue, identified during a routine inspection, appears to be related to a change in the manufacturing process. It has now been corrected, Medtronic said in a statement. 
READ MORE >

Depression linked to a higher stroke risk among heart attack survivors

The new findings, based on data from nearly 500,000 patients, were presented during ACC.22.

READ MORE >
stroke
Share on Twitter Share on Facebook Share on Linkedin

Depression linked to a higher stroke risk among heart attack survivors

Share on Twitter Share on Facebook Share on Linkedin
stroke
The new findings, based on data from nearly 500,000 patients, were presented during ACC.22.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme